|
Question about the naming rule for drugs in Custom Downloads data
|
|
0
|
3
|
June 22, 2025
|
|
Drug-Target validation using CRISPR and PRISM repurposing dataset
|
|
0
|
9
|
June 7, 2025
|
|
Question about PRISM Drug sensitivity AUC data
|
|
7
|
5101
|
April 8, 2025
|
|
Availability of RNA-seq data after drug treatment
|
|
1
|
41
|
April 1, 2025
|
|
Prism secondary drug screening unable to download (google cloud access denied)
|
|
1
|
19
|
March 3, 2025
|
|
Mocs3 interacting drugs
|
|
0
|
10
|
February 26, 2025
|
|
Compound instance
|
|
0
|
15
|
September 11, 2024
|
|
LMFI(log2 median fluorescence intensity values)
|
|
0
|
36
|
July 21, 2024
|
|
PRISM Batch effect
|
|
0
|
30
|
July 19, 2024
|
|
User drug sensitivity (PRISM Repurposing Primary screen)
|
|
3
|
333
|
April 24, 2024
|
|
9-ING-41 repurposing hub data
|
|
1
|
138
|
April 5, 2024
|
|
How to find a specific analysis
|
|
1
|
156
|
March 12, 2024
|
|
Data issue with PRISM drug repurposing dataset
|
|
2
|
174
|
March 8, 2024
|
|
Interpretation of Drug sensitivity AUC and Logfold change value
|
|
8
|
6324
|
March 8, 2024
|
|
Data Removed? Navitoclax single agent data
|
|
5
|
137
|
February 12, 2024
|
|
Prism drug repurposing score
|
|
1
|
448
|
September 12, 2023
|
|
Viability at a given dosage from AUC
|
|
2
|
768
|
August 17, 2023
|
|
Difference between Mifepristone Compounds
|
|
0
|
196
|
July 28, 2023
|
|
How to inverse the AUC value for drug sensitivity screens
|
|
0
|
419
|
January 5, 2023
|
|
About compounds
|
|
0
|
273
|
October 31, 2022
|
|
PRISM data and identified cell lines
|
|
0
|
397
|
September 20, 2022
|
|
Antibody Drug Conjugates
|
|
0
|
300
|
August 29, 2022
|
|
Drug sensitivity (PRISM Repurposing Primary Screen) 19Q4
|
|
2
|
2616
|
July 18, 2022
|
|
NA targets in the PRISM 19Q4 dataset
|
|
2
|
514
|
May 24, 2022
|
|
Are IC50 values downloadable from DepMap log or z-transformed or normalized in some way?
|
|
1
|
752
|
May 3, 2022
|
|
Availability of cell lines from DepMap
|
|
3
|
501
|
April 12, 2022
|
|
Is it possible to separate drug sensitivity into two categories: Sensitive / Resistance?
|
|
1
|
524
|
April 7, 2022
|
|
EGFR inhibitor data of lung cancer cells
|
|
1
|
813
|
January 26, 2022
|
|
How to interpret AUC value
|
|
7
|
2592
|
January 11, 2022
|
|
Estimation of uncertainty around the dose-response curve
|
|
1
|
504
|
January 11, 2022
|
